Drug-eluting stents for secondary prevention of restenosis
- 25 October 2004
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 63 (3) , 265-266
- https://doi.org/10.1002/ccd.20199
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent RestenosisCirculation, 2004
- Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosisJournal of the American College of Cardiology, 2004
- Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placementAmerican Heart Journal, 2004
- Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent RestenosisCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Outcome after treatment of coronary in-stent restenosis Results from a systematic review using meta-analysis techniquesEuropean Heart Journal, 2003
- Restenosis after coronary placement of various stent typesThe American Journal of Cardiology, 2001
- Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosisCatheterization and Cardiovascular Interventions, 1999